Residents

Hera Therapeutics Inc.

Hera Therapeutics Inc.

Using a novel new medicinal chemistry platform, HTI is focused on the development and commercialization of direct acting antivirals for infections with the human papilloma virus, human and animal retroviruses and herpes group viruses.

Area of focus: 
Infectious Diseases & Vaccines
Commencement date: 
03/13/2013

Share